David Attwood
CEO
David brings extensive cannabis sector knowledge along with a strategic view of emerging opportunities in regulated markets.
Previously, David was CFO of CanPharma, the German medicinal cannabis sales and distribution company acquired by Health House International in August 2021. Prior to CanPharma, David led the consulting team at cannabis industry insights leader, Prohibition Partners. He has also held several roles in other regulated sectors and was a manager in Tax and Legal at PwC.
David holds an undergraduate degree in law (LLB, Nottingham University) and an MBA (IESE, Barcelona); and is qualified as a chartered accountant (ICAEW).
Robert Beenstock
Executive Director UK (Finance)
Robert has extensive corporate and financial experience and has been part of the UK Health House team for the past 2 years. He is a Director of the Group’s UK subsidiary, Health House Holdings Limited, and is a member of the Group Executive Team.
Robert is responsible for the Group’s UK based businesses – P&D Pharmaceuticals which supplies pharmacy medicines and hospital supplies to UK and European customers and Gees Pharmacy, an online community pharmacy.
Robert is a qualified Chartered Accountant.